Tag: Pharmaceuticals
Business & Industry
Incyte Expands Haematology Portfolio with Vega Acquisition
Incyte has agreed to acquire Vega Therapeutics, a subsidiary of Star Therapeutics, in a transaction valued at up to $2bn, reinforcing its presence in...
Business & Industry
GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition
GSK has agreed to acquire Nuvalent in a transaction valued at $10.6 billion, positioning the UK-based pharmaceutical company for its largest acquisition in more...
Business & Industry
Firefly Bio Acquisition Strengthens J&J Cancer Pipeline
Johnson & Johnson (J&J) has entered into a definitive agreement to acquire Firefly Bio for $1bn in cash, a move aimed at expanding its...
BioPharma
Daewoong and Chime Biologics Partner for Biosimilar Push
Chime Biologics and Daewoong Pharmaceutical have entered into a strategic collaboration to develop and manufacture a dupilumab biosimilar candidate referencing Dupixent for global markets....
Business & Industry
SK Biopharmaceuticals Opens LinX Hub for Korean Biotech
SK Biopharmaceuticals has established a new innovation platform in the United States aimed at helping Korean biotechnology and pharmaceutical companies expand their presence in...
Business & Industry
Sanofi and Owkin Partner to Co-Develop Agentic AI Tools for Drug Discovery
Sanofi has entered into a multi-year agreement with France-based agentic AI company Owkin to jointly develop next-generation AI-driven biopharma agents. The partnership includes a...
Business & Industry
Boehringer’s Survodutide Cuts Visceral and Liver Fat While Preserving Lean Mass in Late-Stage Trial
German pharmaceutical company Boehringer Ingelheim has reported that its experimental obesity drug, survodutide, significantly reduced visceral abdominal fat and liver fat while largely preserving...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read